ACTN1, upregulated in OC and linked to poor prognosis, promotes tumor growth, EMT, and M2 macrophage polarization via ERK1/2 signaling; FBXO25 interacts upstream, and ERK1/2 inhibition partially reverses these effects. Here, FBXO25 is linked to neoplasm.